CUI1 stringlengths 8 8 | RELA stringlengths 3 54 | CUI2 stringlengths 8 8 | Name1 stringlengths 1 2.86k ⌀ | Name2 stringlengths 1 2.86k ⌀ | Def1 stringlengths 1 8.95k ⌀ | Def2 stringlengths 1 8.95k ⌀ |
|---|---|---|---|---|---|---|
C0000618 | has_component | C0281120 | mercaptopurine | Asparaginase/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281122 | mercaptopurine | Asparaginase/Dexamethasone/Doxorubicin/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281124 | mercaptopurine | Asparaginase/Dexamethasone/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281125 | mercaptopurine | Dexamethasone/Doxorubicin/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281126 | mercaptopurine | Dexamethasone/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281127 | mercaptopurine | Dexamethasone/Mercaptopurine/Methotrexate/Vincristine Combination | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281131 | mercaptopurine | Doxorubicin/Filgrastim/Mercaptopurine/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281212 | mercaptopurine | Asparaginase/Daunorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281213 | mercaptopurine | Cyclophosphamide/Cytarabine/Mercaptopurine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281217 | mercaptopurine | Dexamethasone/Mercaptopurine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281226 | mercaptopurine | Cytarabine/Etoposide/Ifosfamide/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281272 | mercaptopurine | Leucovorin Calcium/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281273 | mercaptopurine | Asparaginase/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281315 | mercaptopurine | Cytarabine/Mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281319 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Doxorubicin/Mercaptopurine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281320 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281321 | mercaptopurine | Asparaginase/Daunorubicin/Dexamethasone/Ifosfamide/Mercaptopurine/Methotrexate/Vindesine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281363 | mercaptopurine | Asparaginase/Cytarabine/Dexamethasone/Doxorubicin/Mercaptopurine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281364 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Mercaptopurine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281365 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281402 | mercaptopurine | Asparaginase/Cyclophosphamide/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281403 | mercaptopurine | Cytarabine/Mercaptopurine/Methotrexate/Teniposide/Thioguanine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338125 | mercaptopurine | Interferon Alfa/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338168 | mercaptopurine | Interferon Alfa/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338220 | mercaptopurine | Cyclophosphamide/Cytarabine/Mercaptopurine/Pegaspargase/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338260 | mercaptopurine | Mercaptopurine/Methotrexate/Tretinoin | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338264 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Etoposide/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338302 | mercaptopurine | Asparaginase/Dexrazoxane/Doxorubicin/Mercaptopurine/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338303 | mercaptopurine | Asparaginase/dexrazoxane/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338304 | mercaptopurine | Asparaginase/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338305 | mercaptopurine | Dexrazoxane/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338308 | mercaptopurine | Mercaptopurine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338320 | mercaptopurine | Cyclophosphamide/Cytarabine/Etoposide/Mercaptopurine/Methotrexate/Prednisolone/Thioguanine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338331 | mercaptopurine | Mercaptopurine/Prednisolone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0338360 | mercaptopurine | Cyclophosphamide/Dexamethasone/Etoposide/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0678015 | mercaptopurine | Cyclophosphamide/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0796447 | mercaptopurine | Asparaginase/Dexamethasone/Mercaptopurine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0796449 | mercaptopurine | Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0796450 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Mercaptopurine/Methotrexate/Thioguanine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0796458 | mercaptopurine | Asparaginase/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0796459 | mercaptopurine | Cytarabine/Mercaptopurine/Methotrexate/Prednisone | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0796535 | mercaptopurine | Asparaginase/Cytarabine/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0796536 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0796538 | mercaptopurine | Asparaginase/Leucovorin Calcium/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0796540 | mercaptopurine | Asparaginase/Cytarabine/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0796542 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Mercaptopurine/Methotrexate/Thioguanine/Vincristine/Vindesine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0879409 | mercaptopurine | Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Prednisone | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0879475 | mercaptopurine | Asparaginase/cyclophosphamide/cytarabine/daunorubicin/dexamethasone/leucovorin calcium/mercaptopurine/methotrexate/thioguanine/vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0879561 | mercaptopurine | Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0935837 | mercaptopurine | Leucovorin Calcium/Mercaptopurine/Methotrexate/Prednisolone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0935841 | mercaptopurine | Leucovorin Calcium/Mercaptopurine/Methotrexate/Prednisolone | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0935846 | mercaptopurine | Mercaptopurine/Methotrexate/Nelarabine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0935859 | mercaptopurine | Cyclophosphamide/cytarabine/mercaptopurine/methotrexate/prednisolone | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0935860 | mercaptopurine | Cyclophosphamide/Cytarabine/Dexamethasone/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1134461 | mercaptopurine | Cyclophosphamide/Dexamethasone/Etoposide/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1134462 | mercaptopurine | Dexamethasone/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1327949 | mercaptopurine | Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vinblastine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1327984 | mercaptopurine | Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Pegaspargase/Thioguanine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1327985 | mercaptopurine | Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1541347 | mercaptopurine | alemtuzumab/mercaptopurine/methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1541370 | mercaptopurine | cyclophosphamide/dexamethasone/mercaptopurine/methotrexate/vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1541371 | mercaptopurine | cyclophosphamide/etoposide/leuvocorin calcium/mercaptopurine/methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1541372 | mercaptopurine | cyclophosphamide/cytarabine/etoposide/mercaptopurine/methotrexate/pegaspargase | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1541493 | mercaptopurine | mercaptopurine/methotrexate/pegaspargase/vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C5779653 | mercaptopurine | Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C0722911 | mercaptopurine | Purinethol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C0729099 | mercaptopurine | Leukerin | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513133 | mercaptopurine | Mercaptopurinum | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513134 | mercaptopurine | Alti-Mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513135 | mercaptopurine | Flocofil | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513136 | mercaptopurine | Ismipur | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513137 | mercaptopurine | Mercaleukim | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513138 | mercaptopurine | Mercaptina | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513139 | mercaptopurine | Purinethiol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | inverse_isa | C0021081 | mercaptopurine | Immunosuppressive Agents | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to preve... |
C0000618 | inverse_isa | C0280038 | mercaptopurine | Purine antagonist | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | An antimetabolite that affects the metabolism and utilization of purines. |
C0000618 | is_physiologic_effect_of_chemical_or_drug | C0021080 | mercaptopurine | Natural immunosuppression | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | natural, usually physiologic downregulation of the immune system; compare with ARTIFICIAL IMMUNOSUPPRESSION. |
C0000618 | chemotherapy_regimen_has_component | C0057181 | mercaptopurine | cytarabine/daunorubicin/mercaptopurine/prednisolone | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | A regimen consisting of cytarabine, daunorubicin, mercaptopurine, and prednisolone that may be used in the treatment of acute myeloid leukemia (AML). |
C0000618 | chemotherapy_regimen_has_component | C0071715 | mercaptopurine | Mercaptopurine/Methotrexate/Prednisone/Vincristine Regimen | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | A regimen consisting of mercaptopurine, methotrexate, prednisone and vincristine that may be used in the treatment of acute lymphoblastic leukemia (ALL). |
C0000618 | chemotherapy_regimen_has_component | C0278667 | mercaptopurine | Asparaginase/Mercaptopurine/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0278668 | mercaptopurine | Cytarabine/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0278705 | mercaptopurine | Cyclophosphamide/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0278896 | mercaptopurine | Carmustine/Cyclophosphamide/Dactinomycin/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0278902 | mercaptopurine | Asparaginase/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0278903 | mercaptopurine | Asparaginase/Doxorubicin/Mercaptopurine/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0278905 | mercaptopurine | Mercaptopurine/Methotrexate/Prednisone/Vindesine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0278916 | mercaptopurine | Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate Combination | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0278923 | mercaptopurine | Cyclophosphamide/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0278924 | mercaptopurine | Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0278933 | mercaptopurine | Mercaptopurine/Methotrexate/Pentostatin | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0279062 | mercaptopurine | Cyclophosphamide/Cytarabine/Mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0279080 | mercaptopurine | Cytarabine/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0279247 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0279276 | mercaptopurine | doxorubicin/mercaptopurine/prednisone/vincristine protocol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0279351 | mercaptopurine | Ancitabine Hydrochloride/Daunorubicin/Mercaptopurine/Prednisolone | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0279391 | mercaptopurine | mercaptopurine/methotrexate/vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0279444 | mercaptopurine | Cyclophosphamide/Mercaptopurine/Prednisone/Vincristine Regimen | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | A regimen consisting of vincristine, cyclophosphamide, mercaptopurine, and prednisone that may be used in the treatment of central nervous system (CNS) lymphoma. |
C0000618 | chemotherapy_regimen_has_component | C0279463 | mercaptopurine | Cytarabine/Doxorubicin/Mercaptopurine/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0279469 | mercaptopurine | Cytarabine/Doxorubicin/Mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | chemotherapy_regimen_has_component | C0279537 | mercaptopurine | Daunorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.